Glaxosmithkline | GSK - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 435.86B 8.73B 2026-08
Amgen USD 209.65B 14.21B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Aurora Cannabis CAD 193.82M 133.39M 2026-03
Bausch Health Companies USD 3.48B 873.55M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Canopy Growth CAD 557.13M 99.33M 2026-03
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Drreddys Laboratories INR 11.07B 619M 2026-03
Eli Lilly USD 1.11T 18.32B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
J&J USD 611.36B 32.21B 2026-06
Merck USD 324.18B 6.81B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Pacira USD 1.28B 286M 2026-08
Perrigo USD 1.45B 135M 2026-08
Pfizer USD 153.17B 14.73B 2026-08
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.7B 463M 2026-08
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Supernus Pharmaceuticals USD 2.58B 116M 2026-08
Takeda JPY 8.2T 809.7B 2026-06
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Zoetis USD 35.38B 5.25B 2026-08